Dr. med. Nikolaus Wagner
An Open-Label, Randomized, Controlled Multi-Center Study of The Efficacy of Daromun (L19IL2 + L19TNF) Neoadjuvant Intratumoral Treatment Followed by Surgery and Adjuvant Therapy Versus Surgery and Adjuvant Therapy in Clinical Stage IIIB/C Melanoma Patients
Jul 11, 2022
Clinical Studies - Jul 11, 2022 - Dec 31, 2026
Ongoing
Project leader: Wagner Nikolaus
Two cohort registry study for patients with advanced CSCC treated with Cemiplimab or other approaches
Jul 1, 2022
Clinical Studies - Jul 1, 2022 - Dec 31, 2025
Ongoing
Project leader: Wagner Nikolaus
Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland – BERINGMELANOMA
Sep 7, 2021
Clinical Studies - Sep 7, 2021 - Oct 1, 2027
Ongoing
Project leader: Wagner Nikolaus
Translation of pre-treatment tumor kinetics and clinical and serological markers of the immune system in the treatment of advanced melanoma
Jan 1, 2021Bei diesem Projekt geht es um die Charakterisierung des Therapieansprechens von Melanommetastasen unter Systemtherapie mit anti-PD-1 Antikörpern, kombinierter Immuntherapie mit dem anti-PD-1 Antikörper Nivolumab und dem anti-CTLA-4 Antikörper Ipilimu...
Clinical Studies - Jan 1, 2021 - Dec 31, 2021
Completed
Project leader: Wagner Nikolaus